Human Immunodeficiency Virus (HIV) Infections Completed Phase 2 Trials for INCB-9471 (DB12960)

Also known as: HIV Infections / Human Immunodeficiency Virus-Infection / Infection, Human Immunodeficiency Virus / HIV INFECTION / Human Immunodeficiency Virus Infection / Human Immunodeficiency Virus Infections / Human Immunodeficiency Virus (HIV) Infection / HIV-Infections / HIV-infection / Human Immunodeficiency Virus Infection (HIV) / [X]Human immunodeficiency virus disease / Human immunodeficiency virus [HIV] disease / HIV disease / HIV infection NOS / Human immunodeficiency virus syndrome / Human immunodeficiency virus infection, unspecified

IndicationStatusPhase
DBCOND0035016 (Human Immunodeficiency Virus (HIV) Infections)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00393120Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected PatientsTreatment